Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nakazato

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|June 5, 1999
In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001S Chaki, S Okuyama, A Nakazato, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001S Okuyama, S Chaki, N Kawashima, et al.
Life Sciences|January 1, 1994
NE-100, a novel sigma receptor ligand: effect on phencyclidine-induced behaviors in rats, dogs and monkeysS Okuyama, Y Imagawa, T Sakagawa, et al.
Life Sciences|May 13, 1999
Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106S Okuyama, S Chaki, R Yoshikawa, et al.
Systematic and Applied Microbiology|August 10, 2000
Divergence of glyceraldehyde-3-phosphate dehydrogenase isozymes in Saccharomyces cerevisiae complexT Kadokura, T Ito, S Takano, et al.
Yeast (Chichester, England)|July 24, 1998
Comparison of the structural characteristics of chromosome VI in Saccharomyces sensu stricto: the divergence, species-dependent features and uniqueness of saké yeastsA Nakazato, T Kadokura, M Amano, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonistsA Nakazato, T Kumagai, K Sakagami, et al.
Life Sciences|January 1, 1993
NE-100, a novel sigma receptor ligand: in vivo testsS Okuyama, Y Imagawa, S Ogawa, et al.
British Journal of Pharmacology|June 1, 1997
The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in ratsS Okuyama, S Chaki, N Kawashima, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1997
In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045)S Okuyama, S Chaki, R Yoshikawa, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|June 5, 1999
In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001S Chaki, S Okuyama, A Nakazato, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001S Okuyama, S Chaki, N Kawashima, et al.
Life Sciences|January 1, 1994
NE-100, a novel sigma receptor ligand: effect on phencyclidine-induced behaviors in rats, dogs and monkeysS Okuyama, Y Imagawa, T Sakagawa, et al.
Life Sciences|May 13, 1999
Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106S Okuyama, S Chaki, R Yoshikawa, et al.
Systematic and Applied Microbiology|August 10, 2000
Divergence of glyceraldehyde-3-phosphate dehydrogenase isozymes in Saccharomyces cerevisiae complexT Kadokura, T Ito, S Takano, et al.
Yeast (Chichester, England)|July 24, 1998
Comparison of the structural characteristics of chromosome VI in Saccharomyces sensu stricto: the divergence, species-dependent features and uniqueness of saké yeastsA Nakazato, T Kadokura, M Amano, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonistsA Nakazato, T Kumagai, K Sakagami, et al.
Life Sciences|January 1, 1993
NE-100, a novel sigma receptor ligand: in vivo testsS Okuyama, Y Imagawa, S Ogawa, et al.
British Journal of Pharmacology|June 1, 1997
The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in ratsS Okuyama, S Chaki, N Kawashima, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1997
In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045)S Okuyama, S Chaki, R Yoshikawa, et al.
Pageof 4